Related references
Note: Only part of the references are listed.Afatinib induces apoptosis in NSCLC without EGFR mutation through Elk-1-mediated suppression of CIP2A
Ting-Ting Chao et al.
ONCOTARGET (2015)
ERKs in Cancer: Friends or Foes?
Xavier Deschenes-Simard et al.
CANCER RESEARCH (2014)
TGF-β-Smad2 dependent activation of CDC 25A plays an important role in cell proliferation through NFAT activation in metastatic breast cancer cells
Suman Sengupta et al.
CELLULAR SIGNALLING (2014)
New tumor suppressor CXXC finger protein 4 inactivates mitogen activated protein kinase signaling
Haiqi Lu et al.
FEBS LETTERS (2014)
Function and mechanism of tumor suppressor gene LRRC4/NGL-2
Peiyao Li et al.
MOLECULAR CANCER (2014)
A Novel p38 Mitogen-activated Protein Kinase/Elk-1 Transcription Factor-dependent Molecular Mechanism Underlying Abnormal Endothelial Cell Proliferation in Plexogenic Pulmonary Arterial Hypertension
Monal Patel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Schnurri-3 regulates ERK downstream of WNT signaling in osteoblasts
Jae-Hyuck Shim et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Serotonin promotes the proliferation of serum-deprived hepatocellular carcinoma cells via upregulation of FOXO3a
Chao Liang et al.
MOLECULAR CANCER (2013)
Cdc25A promotes cell survival by stimulating NF-κB activity through IκB-α phosphorylation and destabilization
Hey-Young Hong et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
The tumour suppressor FOXO3 is a key regulator of mantle cell lymphoma proliferation and survival
Antonia Obrador-Hevia et al.
BRITISH JOURNAL OF HAEMATOLOGY (2012)
Sef Downregulation by Ras Causes MEK1/2 to Become Aberrantly Nuclear Localized Leading to Polyploidy and Neoplastic Transformation
Stephanie Duhamel et al.
CANCER RESEARCH (2012)
LRRC4 Inhibits Glioma Cell Growth and Invasion Through a miR-185-Dependent Pathway
Hailin Tang et al.
CURRENT CANCER DRUG TARGETS (2012)
Targeting the MAPK-RAS-RAF signaling pathway in cancer therapy
Libero Santarpia et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2012)
Both mitogen-activated protein kinase (MAPK)/extracellular-signal-regulated kinases (ERK) 1/2 and phosphatidylinositide-3-OH kinase (PI3K)/Akt pathways regulate activation of E-twenty-six (ETS)-like transcription factor 1 (Elk-1) in U138 glioblastoma cells
Melike Mut et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2012)
Resistance to EGF receptor inhibitors in glioblastoma mediated by phosphorylation of the PTEN tumor suppressor at tyrosine 240
Tim R. Fenton et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Characterization of ERK Docking Domain Inhibitors that Induce Apoptosis by Targeting Rsk-1 and Caspase-9
Sarice R. Boston et al.
BMC CANCER (2011)
Structural basis of p38α regulation by hematopoietic tyrosine phosphatase
Dana M. Francis et al.
NATURE CHEMICAL BIOLOGY (2011)
Pathological roles of MAPK signaling pathways in human diseases
Eun Kyung Kim et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2010)
IκB kinase overcomes PI3K/Akt and ERK/MAPK to control FOXO3a activity in acute myeloid leukemia
Nicolas Chapuis et al.
BLOOD (2010)
The cell polarity regulator hScrib controls ERK activation through a KIM site-dependent interaction
K. Nagasaka et al.
ONCOGENE (2010)
p21-activated kinase 4 regulates ovarian cancer cell proliferation, migration, and invasion and contributes to poor prognosis in patients
Michelle K. Y. Siu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Trans-synaptic EphB2-ephrin-B3 interaction regulates excitatory synapse density by inhibition of postsynaptic MAPK signaling
Andrew C. McClelland et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Trans-synaptic adhesion between NGL-3 and LAR regulates the formation of excitatory synapses
Jooyeon Woo et al.
NATURE NEUROSCIENCE (2009)
Promoter Hypermethylation-mediated Inactivation of LRRC4 in Gliomas
Zuping Zhang et al.
BMC MOLECULAR BIOLOGY (2008)
Advances in the development of cancer therapeutics directed against the RAS-mitogen-activated protein kinase pathway
Judith S. Sebolt-Leopold
CLINICAL CANCER RESEARCH (2008)
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
L. Chin et al.
NATURE (2008)
LRRC4 inhibits glioblastoma cell proliferation, migration, and angiogenesis by downregulating pleiotropic cytokine expression and responses
Minghua Wu et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2008)
LRRC4 inhibits human glioblastoma cells proliferation, invasion, and proMMP-2 activation by reducing SDF-1 alpha/CXCR4-mediated ERK1/2 and Akt signaling pathways
Minghua Wu et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2008)
Leucine-rich repeat C4 protein is involved in nervous tissue development and neurite outgrowth, and induction of glioma cell differentiation
Minghua Wu et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2007)
Differential regulation and properties of MAPKs
M. Raman et al.
ONCOGENE (2007)
Regulation of Cdc25C by ERK-MAP kinases during the G2/M transition
Ruoning Wang et al.
CELL (2007)
Hyperactive Ras in developmental disorders and cancer
Suzanne Schubbert et al.
NATURE REVIEWS CANCER (2007)
LRRC4 controls in vitro invasion of glioblastoma cells through inhibiting RPTP-zeta expression
Minghua Wu et al.
JOURNAL OF NEURO-ONCOLOGY (2006)
NGL family PSD-95-interacting adhesion molecules regulate excitatory synapse formation
Seho Kim et al.
NATURE NEUROSCIENCE (2006)
LRRC4, a putative tumor suppressor gene, requires a functional leucine-rich repeat cassette domain to inhibit proliferation of glioma cells in vitro by modulating the extracellular signal-regulated kinase/protein kinase B/nuclear factor-κB pathway
Minghua Wu et al.
MOLECULAR BIOLOGY OF THE CELL (2006)
Docking interactions induce exposure of activation loop in the MAP kinase ERK2
Tianjun Zhou et al.
STRUCTURE (2006)
Structural basis of docking interactions between ERK2 and MAP kinase phosphatase 3
SJ Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
The extracellular signal-regulated kinase: Multiple substrates regulate diverse cellular functions
S Yoon et al.
GROWTH FACTORS (2006)
Study of a novel brain relatively specific gene LRRC4 involved in glioma tumorigenesis suppression using the Tet-on system
QH Zhang et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2005)
Cdc25A and ERK interaction: EGFR-independent ERK activation by a protein phosphatase Cdc25A inhibitor, compound 5
ZQ Wang et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2005)
Expression and functional characterization of LRRC4, a novel brain-specific member of the LRR superfamily
QH Zhang et al.
FEBS LETTERS (2005)
Docking motif interactions in MAP kinases revealed by hydrogen exchange mass spectrometry
T Lee et al.
MOLECULAR CELL (2004)
Subcellular localization determines the protective effects of activated ERK2 against distinct apoptogenic stimuli in myeloid leukemia cells
N Ajenjo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
The netrin-G1 ligand NGL-1 promotes the outgrowth of thalamocortical axons
JC Lin et al.
NATURE NEUROSCIENCE (2003)
Hydrophobic as well as charged residues in both MEK1 and ERK2 are important for their proper docking
BE Xu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
A conserved docking motif in MAP kinases common to substrates, activators and regulators
T Tanoue et al.
NATURE CELL BIOLOGY (2000)
Share Paper
